Vir Biotechnology, Inc. (VIR)
11.70
+0.58
(+5.22%)
USD |
NASDAQ |
Oct 09, 16:00
11.70
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology 30-Day Average Daily Volume : 2.296M for Oct. 9, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.296M |
| October 08, 2026 | 2.289M |
| October 07, 2026 | 2.261M |
| October 06, 2026 | 2.241M |
| October 05, 2026 | 2.213M |
| October 02, 2026 | 2.167M |
| October 01, 2026 | 2.130M |
| September 30, 2026 | 2.113M |
| September 29, 2026 | 2.105M |
| September 28, 2026 | 2.101M |
| September 25, 2026 | 2.089M |
| September 24, 2026 | 2.093M |
| September 23, 2026 | 2.056M |
| September 22, 2026 | 2.040M |
| September 21, 2026 | 2.028M |
| September 18, 2026 | 2.035M |
| September 17, 2026 | 1.888M |
| September 16, 2026 | 1.877M |
| September 15, 2026 | 1.864M |
| September 14, 2026 | 1.829M |
| September 11, 2026 | 1.805M |
| September 10, 2026 | 1.776M |
| September 09, 2026 | 1.761M |
| September 08, 2026 | 1.743M |
| September 04, 2026 | 1.745M |
| Date | Value |
|---|---|
| September 03, 2026 | 1.778M |
| September 02, 2026 | 1.743M |
| September 01, 2026 | 1.691M |
| August 31, 2026 | 1.656M |
| August 28, 2026 | 1.604M |
| August 27, 2026 | 1.601M |
| August 26, 2026 | 1.608M |
| August 25, 2026 | 1.574M |
| August 24, 2026 | 1.531M |
| August 21, 2026 | 1.537M |
| August 20, 2026 | 1.534M |
| August 19, 2026 | 1.542M |
| August 18, 2026 | 1.537M |
| August 17, 2026 | 1.533M |
| August 14, 2026 | 1.536M |
| August 13, 2026 | 1.541M |
| August 12, 2026 | 1.563M |
| August 11, 2026 | 1.588M |
| August 10, 2026 | 1.612M |
| August 07, 2026 | 1.813M |
| August 06, 2026 | 1.802M |
| August 05, 2026 | 1.794M |
| August 04, 2026 | 1.830M |
| August 03, 2026 | 1.833M |
| July 31, 2026 | 2.085M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Moderna, Inc. | 17.01M |
| Vaxcyte, Inc. | 2.683M |
| Caribou Biosciences, Inc. | 3.400M |
| Arrowhead Pharmaceuticals, Inc. | 2.142M |
| Oncolytics Biotech, Inc. | 1.076M |